Mitsuru Nakazawa was born in Hakodate, Hokkaido, Japan. He graduated from the Tohoku University School of Medicine, Sendai, Japan in 1980 and received the M.D. degree. After finishing ophthalmology residency at Tohoku University Hospital, he studied molecular biology at the University of Cincinnati, Ohio, USA from 1985 to 1988. He received the Ph.D. degree, in 1989, from Tohoku University, Sendai, Japan. He has been appointed as a Professor and Chairman of the Department of Ophthalmology, Graduate School of Medicine, Hirosaki University since 1998. His main research interests are clinical, biochemical, and molecular genetic aspects of retinitis pigmentosa, allied hereditary retinal degeneration, and other vitreoretinal diseases. He contributed to the academic field by identifying novel mutations in peripherin/RDS, arrestin, PRPF31, and GCAP2 genes in patients with retinitis pigmentosa, cone-rod dystrophy, central areolar choroidal dystrophy, and/or Oguchi disease, respectively, and demonstrating their phenotypic characteristics as well. In addition, he has been studying mechanisms of photoreceptor degeneration and protection from apoptosis, particularly modulating photoreceptor apoptosis by using pharmaceutical agents like calcium antagonist and calpain inhibitor, and so on. He is an Editorial Board Member of the Japanese Journal of Ophthalmology and the Japanese Journal of Clinical Ophthalmology, Councilor of the Japanese Society of Ophthalmology, Board Director of the Japanese Society of Ophthalmic Diabetology and the Japanese Society of Ophthalmic Circulation, Auditor of the Vitreoretinal Society of Japan, and the Past-President of the Annual Meetings of the Vitreoretinal Society of Japan and the Japanese Society of Ophthalmic Diabetology.
Biography Updated on 13 April 2011